138 related articles for article (PubMed ID: 37838475)
1. Evaluation of phenotypical and genotypical methods for the identification and typing of Stenotrophomonas maltophilia isolated from a pharmaceutical facility.
de Miranda RVDSL; Monteiro GM; da Costa LV; Dos Santos MCS; Dos Reis CMF; Braga LMPDS; Forsythe SJ; Villas Bôas MHS; Brandão MLL
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37838475
[TBL] [Abstract][Full Text] [Related]
2. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
4.
Alcaraz E; Garcia C; Papalia M; Vay C; Friedman L; Passerini de Rossi B
J Med Microbiol; 2018 Jul; 67(7):992-1002. PubMed ID: 29799387
[No Abstract] [Full Text] [Related]
5. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
6. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
[TBL] [Abstract][Full Text] [Related]
7. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility pattern of
Elufisan TO; Luna ICR; Oyedara OO; Varela AS; García VB; Oluyide BO; Treviño SF; López MAV; Guo X
Afr Health Sci; 2020 Mar; 20(1):168-181. PubMed ID: 33402905
[TBL] [Abstract][Full Text] [Related]
9. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
10. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
11. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
13. Relationship between antibiotic resistance with class 1 integron and SmeDEF efflux pump encoding genes in clinical isolates of Stenotrophomonas maltophilia.
Bafandeh Zamanpour S; Yousefi Mashouf R; Salimizand H; Nazari M; Alikhani MY; Farajnia S
J Appl Genet; 2023 Sep; 64(3):591-597. PubMed ID: 37574492
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
16. An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital.
Caylan R; Kaklikkaya N; Aydin K; Aydin F; Yilmaz G; Ozgumus B; Koksal I
Jpn J Infect Dis; 2004 Apr; 57(2):37-40. PubMed ID: 15118205
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
Church D; Lloyd T; Peirano G; Pitout J
Scand J Infect Dis; 2013 Apr; 45(4):265-70. PubMed ID: 23113657
[TBL] [Abstract][Full Text] [Related]
18. Innovative Strategies Against Superbugs: Developing an AI-CDSS for Precise Stenotrophomonas maltophilia Treatment.
Lin TH; Chung HY; Jian MJ; Chang CK; Lin HH; Yu CM; Perng CL; Chang FY; Chen CW; Shang HS
J Glob Antimicrob Resist; 2024 Jun; ():. PubMed ID: 38909685
[TBL] [Abstract][Full Text] [Related]
19. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
Wei C; Ni W; Cai X; Cui J
Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
